Literature DB >> 2767338

Mean glomerular volume and rate of development of diabetic nephropathy.

R W Bilous1, S M Mauer, D E Sutherland, M W Steffes.   

Abstract

We studied kidney glomerular structure and function in two groups of type I (insulin-dependent) diabetic subjects with 14-16 yr (group 1, n = 16) and 24-26 yr (group 2, n = 13) duration of diabetes and compared them to a group of 18 nondiabetic subjects with similar age ranges. Within each diabetic group, subjects were selected for normal kidney function (urinary albumin excretion less than 40 mg/24 h, normal blood pressure, creatinine clearance greater than 90 ml.min-1.1.73 m-2) or for nephropathy (urinary albumin excretion greater than 200 mg/24 h). Morphometric analysis of glomeruli revealed a significantly larger mean glomerular volume in subjects with nephropathy (group 2). Mesangial volumes were significantly greater in the nephropathic than the normoalbuminuric diabetic subjects in each group, but filtration surface per glomerulus was constant among all subjects. The percentage of sclerosed glomeruli was also significantly increased in the nephropathic subjects compared with the subjects with normal kidney function, in whom sclerosed glomeruli did not exceed 8%. In addition, there was a significant correlation between percentage of globally sclerosed glomeruli and glomerular volume in group 2 (rs = .79, P less than .01) but not group 1 (rs = -.20, NS) subjects. Thus, glomerular size or individual capacity for glomerular expansion may determine the rate of progression of the loss of kidney function in subjects destined to develop diabetic nephropathy.

Entities:  

Mesh:

Year:  1989        PMID: 2767338     DOI: 10.2337/diab.38.9.1142

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  28 in total

1.  Applicability of the glomerular size distribution coefficient in assessing human glomerular volume: the Weibel and Gomez method revisited.

Authors:  Terry Samuel; Wendy E Hoy; Rebecca Douglas-Denton; Michael D Hughson; John F Bertram
Journal:  J Anat       Date:  2007-04-05       Impact factor: 2.610

Review 2.  Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients.

Authors:  Michael Mauer; Maria Luiza Caramori; Paola Fioretto; Behzad Najafian
Journal:  Nephrol Dial Transplant       Date:  2014-09-01       Impact factor: 5.992

3.  Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype.

Authors:  C W Heilig; L A Concepcion; B L Riser; S O Freytag; M Zhu; P Cortes
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

4.  Nephron number and individual glomerular volumes in male Caucasian and African American subjects.

Authors:  Monika A Zimanyi; Wendy E Hoy; Rebecca N Douglas-Denton; Michael D Hughson; Libby M Holden; John F Bertram
Journal:  Nephrol Dial Transplant       Date:  2009-03-18       Impact factor: 5.992

5.  Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice.

Authors:  S Ghosh; M Khazaei; F Moien-Afshari; L S Ang; D J Granville; C B Verchere; S R Dunn; P McCue; A Mizisin; K Sharma; I Laher
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

Review 6.  Morphologic features of declining renal function in type 1 diabetes.

Authors:  Behzad Najafian; Michael Mauer
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 7.  Temporal profile of diabetic nephropathy pathologic changes.

Authors:  Cecilia Ponchiardi; Michael Mauer; Behzad Najafian
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

8.  Urocortin ameliorates diabetic nephropathy in obese db/db mice.

Authors:  X Li; J Hu; R Zhang; X Sun; Q Zhang; X Guan; J Chen; Q Zhu; S Li
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

9.  Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.

Authors:  H Vlassara; L J Striker; S Teichberg; H Fuh; Y M Li; M Steffes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.

Authors:  C W Yang; H Vlassara; E P Peten; C J He; G E Striker; L J Striker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.